CHAMPIONS ONCOLOGY, INC. (CSBR) › Operating IncomeCHAMPIONS ONCOLOGY, INC. (CSBR) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2011: -$5.24M2012: -$9.06M2013: -$6.22M2014: -$6.26M2015: -$13.24M2016: -$10.32M2017: -$6.81M2018: -$1.35M2019: $270.0K2020: -$1.92M2021: $366.0K2022: $607.0K2023: -$5.26M2024: -$7.36M2025: $4.55M$4.55M2011Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025$4.55M+161.9%2024-$7.36M-40.0%2023-$5.26M-965.9%2022$607.0K+65.8%2021$366.0K+119.1%2020-$1.92M-811.5%2019$270.0K+119.9%2018-$1.35M+80.1%2017-$6.81M+34.0%2016-$10.32M+22.1%2015-$13.24M-111.5%2014-$6.26M-0.6%2013-$6.22M+31.4%2012-$9.06M-73.2%2011-$5.24M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share